glp-1 insurance coverage 2026 Weight loss drugs' high costs prompt Cigna to cut employee health plan Upcoming Insurance Changes for GLP-1

The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis: A Review

Changing too many things at once feels like a diet, which triggers resistance

When food and waste sit in the small intestine for longer than they should, it creates an environment where bacteria can can overgrow

Within research settings, BPC-157 is studied as a signaling pathway modulator associated with cytoprotective responses, vascular regulation, and cellular processes involved in connective tissue biology

Again, orforglipron is still being studied and in late clinical trials, but heres the expected timeline: Eli Lilly plans to submit it to the FDA in late 2025 for approval for weight loss in adults with a BMI of 30 or higher, or 27 and higher with a related health condition